Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

2 years ago

JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the…

Safety Shot Set for West Coast Launch on December 7th in California

2 years ago

Media, investors and influencers invited to try Safety Shot and to meet management at Bogies in Westlake Village, California Available…

Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study Evaluating L1-79 to Treat the Core Symptoms of Autism Spectrum Disorder

2 years ago

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals LLC (Yamo), a clinical stage pharmaceutical company, announced today that…

Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference

2 years ago

BERKELEY, Calif. and MAINZ, Germany, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference

2 years ago

BRISBANE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics…

Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference

2 years ago

BOSTON, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells…

Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)

2 years ago

ORION CORPORATION PRESS RELEASE 20 NOVEMBER 2023 at 15.00 EET                       Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral…

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

2 years ago

LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,…

TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment

2 years ago

SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a…

Daré Bioscience and Premier Research Extend Strategic Partnership to Accelerate the Clinical Development of Daré’s Novel Women’s Health Programs

2 years ago

Partnership Aims to Advance Daré’s Reproductive Health Portfolio in a Timely and Capital Efficient MannerSAN DIEGO and MORRISVILLE, N.C., Nov.…